Skip to main content


Log in

Sclerotic changes of cavernous hemangioma in the cirrhotic liver: long-term follow-up using dynamic contrast-enhanced computed tomography

  • Published:
La radiologia medica Aims and scope Submit manuscript



To determine the intra- and extralesional factors that predict sclerotic degeneration of hepatic hemangiomas in the cirrhotic liver on long-term follow-up computed tomography (CT) examinations.

Materials and methods

Fifty-seven hepatic hemangiomas (> 5 mm in diameter) in 41 cirrhotic patients, recruited over a 5-year period (January 2005–December 2009), were subjected to CT to determine which factors predict sclerotic contraction or degeneration in hemangiomas. Prior and follow-up CT examinations (from 2000 to 2018) were included to observe time-related changes. The patients’ gender, age, cause of cirrhosis, progression of background liver cirrhosis, lesion size/location/contrast enhancement pattern, and serum aspartate transaminase to platelet ratio index were correlated with sclerotic changes of each lesion.


According to the dynamic CT features, 36 of 57 (63%) hemangiomas were determined to have sclerotic changes during the follow-up period (1.1–14.4 years, median: 7.8 years), including 28 lesions (49%) reduced by ≥ 20% in diameter. In univariate analysis, age (p = 0.047) and morphological progression of background cirrhosis (p = 0.013) were significantly related to sclerotic change of hemangiomas. In the logistic regression analysis, only morphological progression of background liver cirrhosis independently predicted sclerotic change (odds ratio: 4.88, p = 0.007). With the exception of exophytic location free from size reduction (p = 0.023 in multivariate analysis), no other analyzed factors were significantly correlated with sclerotic changes.


Overall, sclerotic changes of hepatic cavernous hemangioma followed the morphological progression of background liver cirrhosis, while exophytic lesions tended to be free of size reduction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others


  1. Bioulac-Sage P, Laumonier H, Laurent C, Blanc JF, Balabaud C (2008) Benign and malignant vascular tumors of the liver in adults. Semin Liver Disease 28(03):302–314

    Article  Google Scholar 

  2. Gibney RG, Hendin AP, Cooperberg PL (1987) Sonographically detected hepatic hemangiomas: absence of change over time. AJR Am J Roentgenol 149:953–957

    Article  CAS  Google Scholar 

  3. Ronot M, Dioguardi Burgio M, Purcell Y, Pommier R, Brancatelli G, Vilgrain V (2017) Focal lesions in cirrhosis: not always HCC. Eur J Radiol 93:157–168

    Article  Google Scholar 

  4. Gandolfi L, Leo P, Solmi L, Vitelli E, Verros G, Colecchia A (1991) Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut 32:677–680

    Article  CAS  Google Scholar 

  5. Hasan HY, Hinshaw JL, Borman EJ, Gegios A, Leverson G, Winslow ER (2014) Assessing normal growth of hepatic hemangiomas during long-term follow-up. JAMA Surg 149:1266–1271

    Article  Google Scholar 

  6. Jing L, Liang H, Caifeng L et al (2016) New recognition of the natural history and growth pattern of hepatic hemangioma in adults. Hepatol Res 46:727–733

    Article  Google Scholar 

  7. Choi J, Yu JS, Cho ES, Kim JH, Chung JJ (2018) Hepatic cavernous hemangiomas: long-term (%3e 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change. Radiol Med 123:323–330

    Article  Google Scholar 

  8. Dodd GD 3rd, Baron RL, Oliver JH 3rd, Federle MP (1999) Spectrum of imaging findings of the liver in end-stage cirrhosis: part II, focal abnormalities. AJR Am J Roentgenol 173:1185–1192

    Article  Google Scholar 

  9. Brancatelli G, Federle MP, Blachar A, Grazioli L (2001) Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology 219:69–74

    Article  CAS  Google Scholar 

  10. Yu JS, Kim KW, Park MS, Yoon SW (2000) Hepatic cavernous hemangioma in cirrhotic liver: imaging findings. Korean J Radiol 1:185–190

    Article  CAS  Google Scholar 

  11. Galia M, Taibbi A, Marin D et al (2014) Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol 20:222–228

    Article  Google Scholar 

  12. Klotz T, Montoriol PF, Da Ines D, Petitcolin V, Joubert-Zakeyh J, Garcier JM (2013) Hepatic haemangioma: common and uncommon imaging features. Diag Interv Imaging 94:849–859

    Article  CAS  Google Scholar 

  13. Makhlouf HR, Ishak KG (2002) Sclerosed hemangioma and sclerosing cavernous hemangioma of the liver: a comparative clinicopathologic and immunohistochemical study with emphasis on the role of mast cells in their histogenesis. Liver 22:70–78

    Article  Google Scholar 

  14. Chernyak V, Fowler KJ, Kamaya A et al (2018) Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 289:816–830

    Article  Google Scholar 

  15. Ito K, Mitchell DG, Siegelman ES (2002) Cirrhosis: MR imaging features. Magn Reason Imaging Clin N Am 10:75–92

    Article  Google Scholar 

  16. Yu JS, Kim KW, Sung KB, Lee JT, Yoo HS (1997) Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging. Radiology 203:737–742

    Article  CAS  Google Scholar 

  17. Ahn JH, Yu JS, Hwang SH, Chung JJ, Kim JH, Kim KW (2010) Nontumorous arterioportal shunts in the liver: CT and MRI findings considering mechanisms and fate. Eur Radiol 20:385–394

    Article  Google Scholar 

  18. Doyle DJ, Khalili K, Guindi M, Atri M (2007) Imaging features of sclerosed hemangioma. AJR Am J Roentgenol 189:67–72

    Article  Google Scholar 

  19. Ito K, Mitchell DG (2000) Hepatic morphologic changes in cirrhosis: MR imaging findings. Abdom Imaging 25:456–461

    Article  CAS  Google Scholar 

  20. Brancatelli G, Federle MP, Ambrosini R et al (2007) Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 61:57–69

    Article  Google Scholar 

  21. Hanafusa K, Ohashi I, Himeno Y, Suzuki S, Shibuya H (1995) Hepatic hemangioma: findings with two-phase CT. Radiology 196:465–469

    Article  CAS  Google Scholar 

  22. Jeong MG, Yu JS, Kim KW (2000) Hepatic cavernous hemangioma: temporal peritumoral enhancement during multiphase dynamic MR imaging. Radiology 216:692–697

    Article  CAS  Google Scholar 

  23. Kim KW, Kim TK, Han JK, Kim AY, Lee HJ, Choi BI (2001) Hepatic hemangiomas with arterioportal shunt: findings at two-phase CT. Radiology 219:707–711

    Article  CAS  Google Scholar 

  24. Berzigotti A (2017) Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol 67:399–411

    Article  Google Scholar 

  25. Yu JS, Shim JH, Chung JJ, Kim JH, Kim KW (2010) Double contrast-enhanced MRI of viral hepatitis-induced cirrhosis: correlation of gross morphological signs with hepatic fibrosis. Br J Radiol 83:212–217

    Article  CAS  Google Scholar 

  26. Shim JH, Yu JS, Chung JJ, Kim JH, Kim KW (2011) Segmental difference of the hepatic fibrosis from chronic viral hepatitis due to hepatitis B versus C virus infection: comparison using dual contrast material-enhanced MRI. Korean J Radiol 12:431–438

    Article  Google Scholar 

  27. Cross TJ, Calvaruso V, Foxton MR et al (2010) A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation. J Viral Hepat 17:640–649

    Article  CAS  Google Scholar 

  28. Lu W, Zhang YP, Zhu HG et al (2019) Evaluation and comparison of the diagnostic performance of routine blood tests in predicting liver fibrosis in chronic hepatitis B infection. Br J Biomed Sci 76:137–142

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Jeong-Sik Yu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shin, N., Choi, J.A., Choi, J.M. et al. Sclerotic changes of cavernous hemangioma in the cirrhotic liver: long-term follow-up using dynamic contrast-enhanced computed tomography. Radiol med 125, 1225–1232 (2020).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: